IMEUSGLOBAL VENTURE PARTNERSHIP PROGRAMME

IMEUS Global

Global VenturePartnershipProgramme

One Vision. Multiple Ventures.
Shared Prosperity.

Building the businesses that complete the Unified Health Ecosystem through independent Brand Verticals, dedicated human Co-Founders and the right growth partners.

Abstract connected glass structures representing independent ventures within one ecosystem

Each venture builds its own commercial success while contributing a defined capability to an intelligent, secure, sustainable and interoperable Health–Business–Finance ecosystem.

The programme

A unified worldview.
Independent entrepreneurship.

The IMEUS Global Venture Partnership Programme (IGVPP) is an IMEUS-led framework for originating, developing and growing Co-Founder-led Brand Verticals. It brings together founding assets, entrepreneurial leadership and venture-specific partnerships.

01 / FOUNDATION

IMEUS originates

IMEUS contributes relevant intellectual property, healthcare domain knowledge and shared architecture, with the scope of each contribution agreed for the venture.

02 / LEADERSHIP

Co-Founders lead

A dedicated human Co-Founder leads the company, builds its team and takes responsibility for customers, business performance and outcomes.

03 / GROWTH

Partners accelerate

Investors, accelerators and specialist institutions support each venture according to its stage, market and commercial requirements.

IMEUS Global

The originator and strategic steward of founding IP and ecosystem architecture.

IGVPP

The institutional pathway for venture formation, Co-Founder matching and growth partnerships.

Brand Vertical companies

Independent commercial businesses with their own leadership, customers and agreed integration responsibilities.

MEDTIUM @Global / @Country

A complementary framework for coordinated ecosystem participation and country-level commercial development.

The shared purpose

Value for the six Ps

Our ventures contribute towards an ecosystem that serves the people receiving care, the organisations delivering it and the institutions that finance and plan it.

Person

Greater control of lifelong health information and participation.

Patient

More coordinated care and clearer next steps.

Provider

Clinical productivity and continuity across healthcare workflows.

Payor

Clearer payment processes and evidence of healthcare value.

Planner

Better information for service and resource planning.

Policymaker

Evidence to assess access, quality and sustainability.

These are intended ecosystem outcomes. Each venture defines and measures the outcomes relevant to its customers.

For entrepreneurial leaders

The opportunity to co-found and lead

Build an independent business with a defined place in a larger healthcare ecosystem.

We seek entrepreneurial leaders who can turn domain expertise and relevant founding assets into a product customers choose, a team that delivers and a sustainable company.

  • A clear commercial mandateOwn the venture’s business plan, customer development and execution.
  • Agreed founding participationDefine equity, vesting, responsibilities and remuneration around your contribution and the company’s needs.
  • Relevant IMEUS foundationsAssess available assets, licensing rights, workflow knowledge and access to shared services.
  • AI-supported operationsUse AI to support research, product development and business delivery within defined permissions and human oversight.
  • A pathway to suitable partnersPursue investment, acceleration and market access when the venture’s evidence supports its next step.

For growth partners

A suite of partnerships.
Matched to each venture.

Participate in a selected company or explore a scoped programme relationship. Each engagement starts with a specific venture, a defined contribution and shared expectations.

Venture builders

Support venture formation and entrepreneurial team development, with a clear allocation of founding contributions.

Investors and accelerators

Evaluate focused companies and support their growth through capital, mentorship and fundraising access.

Healthcare and corporate partners

Contribute pilot settings, clinical validation, commercial expertise and appropriate distribution opportunities.

Technology partners

Help ventures develop and operate their technical capabilities, including relevant AI infrastructure and integration services.

Market-access institutions

Support entry into relevant markets and connect ventures with customers and local commercial partners.

Partnership pathways describe the programme’s intended model. Specific engagements depend on mutual agreement and venture readiness.

Selected opportunities

Focused companies.
Distinct growth journeys.

Each Brand Vertical needs a clear buyer, a focused offering and its own evidence of demand. The proposed initial opportunities illustrate different commercial pathways.

Clinical productivity

MEDIVOIZ

Ambient clinical intelligence that supports documentation within the clinician’s workflow.

Initial focus
Clinician adoption and controlled record export.
Evidence to establish
Paid usage, retention and documented time savings.

Individual health ownership

LH-R

A Lifetime Health Repository centred on individual control of personal health information.

Initial focus
Reliable record collection and repeat personal use.
Evidence to establish
Record imports, sustained engagement and willingness to pay for optional services.

Business outcome delivery

IMEUS OE

An Outcomes Engine industry-agnostic core for delivering measurable outcomes through AI-human execution.

Initial focus
One commercially repeatable customer outcome.
Evidence to establish
Real-world results and sustainable delivery economics.
The foundational Brand Vertical portfolio
Hospital-I.comHospital Information System
eKlinik.comClinic Information System
iFarmasi.comPharmacy Information System
Dyntal.comDental Information System
Weltique.comMental Health Information System
LabEcoSys.comLaboratory Information System
CyberRIS.comTeleradiology Information System
TeleAccounting.comTeleaccounting Information System
MEDIVOIZ.comAmbient Clinical Intelligence System
Home2care.comPatient Home Care System
iPatient-Portal.comPatient Portal System
IMEUS-X.comMedical Device Exchange System

Portfolio scope describes the ecosystem capabilities. Maturity, product availability and investment readiness vary by venture. Additional opportunities may join the programme.

The participation principle

Independence with meaningful connection

Ecosystem participation must create value for the individual Brand Vertical.

Each company retains its commercial identity while contributing agreed interoperability capabilities. Shared architecture supports business growth through documented rights and responsibilities.

  • Commercial autonomyDedicated management, financial accounts and customer contracts.
  • Clear IP arrangementsDefined vertical-specific ownership and secure access to shared technology.
  • Purposeful interoperabilityAgreed interfaces and integration obligations that serve customers.
  • Responsible data stewardshipDefined access, consent and safeguards for each deployment.
  • Venture-specific economicsFounding equity, investment and any licensing or shared-service fees follow documented agreements.

The venture pathway

Evidence at every stage

Progress follows customer demand, product performance and delivery economics. Clinical, security and regulatory requirements inform the milestones relevant to each venture.

Originate & establish

Define the customer problem, venture scope, assets and company arrangements.

Co-Found & validate

Appoint dedicated leadership and test a focused offering with customers.

Partner & scale

Match the venture’s evidence and capital needs to appropriate growth partners.

Integrate & evolve

Deliver agreed interoperability as the company and ecosystem grow.

Our founding declaration

One Vision. Multiple Ventures.
Shared Prosperity.

We believe that the future of healthcare will not be realised through isolated applications, fragmented institutions or disconnected commercial interests.

It will emerge from an intelligent, secure and sustainable Unified Health Ecosystem in which independently led enterprises collectively advance the interests of individuals, patients, healthcare providers, payors, planners and policymakers.

The IMEUS Global Venture Partnership Programme exists to make this vision commercially achievable.

We originate and empower Brand Verticals, pair them with entrepreneurial human Co-Founders, augment their execution capabilities with artificial intelligence and connect them to an international network of venture capital, accelerators, technology partners and strategic institutions.

Each venture is empowered to build its own commercial success while contributing to a greater interoperable ecosystem.

Our ambition is not simply to create more startups.

It is to establish a repeatable institutional framework through which entrepreneurial initiative, intellectual property, capital, technology and human ingenuity converge to build the businesses required for a Unified Health Ecosystem.

IMEUS creates the foundation. Co-Founders lead the ventures. Partners accelerate growth. Together, we complete the ecosystem.

An invitation to participate

Your contribution.
A venture’s next chapter.

Introduce your experience, the venture or capability that interests you, and the contribution you would like to explore.

Our first conversation establishes commercial alignment and the next step towards a defined engagement.

  • Prospective Co-FoundersExplore leadership of an independent Brand Vertical.
  • Investors and acceleratorsReview a selected venture and its commercial evidence.
  • Healthcare and corporate partnersExplore a pilot, validation setting or distribution relationship.
  • Technology and institutional partnersContribute a capability that helps a venture reach its next milestone.